Taiwan Veldona human study to start in Sjogren’s. Ainos will initiate a Veldona clinical study in Taiwan for primary Sjogren’s syndrome in December 2024.
What is covered in the Full Insight:
Introduction
Clinical Study Details
Study Objectives
Background on Sjogren’s Syndrome
Previous Clinical Data
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.